Stanford spin-out NuMedii closes $3.5m series A for big data pharma platform.
NuMedii, a big data spin-out of Stanford University, has received $3.5m in a series A round to develop its pharma platform. The round was led by venture firms Claremont Creek Ventures and Lightspeed Venture Partners with participation by Life Science Angels and other angels. NuMedii’s platform looks to pair existing drugs with new disease applications…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
